Expression of β-adrenergic receptors in pediatric malignant brain tumors

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.5, Iss.1, 2013-01, pp. : 221-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis and Angiogenic Tyrosine Kinase Receptor Expression in Pediatric Brain Tumors

By Virág József Kenessey István Haberler Christine Piurkó Violetta Bálint Katalin Döme Balázs Tímár József Garami Miklós Hegedűs Balázs

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 417-426

Springer Publishing Company

Access to resources Recommend Favorite

The Therapy of Infantile Malignant Brain Tumors: Current Status?

By Kalifa Chantal Grill Jacques

Journal of Neuro-Oncology, Vol. 75, Iss. 3, 2005-12 ,pp. : 279-285

Springer Publishing Company

Access to resources Recommend Favorite

A long-acting β2-adrenergic agonist increases the expression of muscarine cholinergic subtype3 receptors by activating the β2-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cells

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4121-4128

Spandidos Publications

Access to resources Recommend Favorite

New Delivery Approaches for Pediatric Brain Tumors

By Pollack Ian Keating Robert

Journal of Neuro-Oncology, Vol. 75, Iss. 3, 2005-12 ,pp. : 315-326

Springer Publishing Company

Access to resources Recommend Favorite

Molecularly Targeted Therapy for Pediatric Brain Tumors

By KE Warren

Journal of Neuro-Oncology, Vol. 75, Iss. 3, 2005-12 ,pp. : 335-343

Springer Publishing Company

Access to resources Recommend Favorite